Joining the DOTS

National “twin study”

BMJ 2008; 336 doi: 10.1136/bmj.39514.423090.80 (Published 13 March 2008)
Cite this as: BMJ 2008;336:574.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ulf R Dahle, senior scientist
  1. 1Norwegian Institute of Public Health, PO Box 4404 Nydalen, 0403 Oslo, Norway
  1. ulf.dahle{at}fhi.no

    Davies and Squire say it’s too soon to conclude on the efficacy of directly observed treatment short courses (DOTS) for treating tuberculosis.1

    Norway and Sweden are sociodemographically, politically, and culturally comparable. However, the Norwegian tuberculosis control programme fully complies with the DOTS strategy promoted by the World Health Organization and …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL